ArticleInvestigative and clinical urology2026
Predictors of benign histology in clinical T1a small renal masses: A large multicenter cohort study.
Article in Investigative and clinical urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThe increasing detection of small renal masses (SRMs, ≤4 cm) has raised concern for overdiagnosis and overtreatment, as a substantial proportion of these lesions prove to be benign. Identifying preoperative predictors of benign histology may help refine treatment selection and reduce unnecessary surgery. MATERIALS AND
methodsWe performed a retrospective multicenter cohort study including patients who underwent partial or radical nephrectomy for clinical T1a renal masses at eight tertiary referral centers in South Korea between 1990 and 2023. Clinicodemographic, laboratory, and radiologic variables were compared between benign and malignant tumors. Independent predictors of benign pathology were identified using multivariable logistic regression.
resultsAmong 5,713 surgically treated renal masses, 289 (5.1%) were benign. Compared with malignant tumors, benign lesions were more common in females (58.8% vs. 28.2%, p<0.001) and were associated with lower body mass index (BMI) (23.60 kg/m² vs. 24.80 kg/m², p<0.001), higher estimated glomerular filtration rate (eGFR) (93.67 mL/min/1.73 m² vs. 84.65 mL/min/1.73 m², p<0.001), and smaller tumor size (20.60 mm vs. 24.86 mm, p<0.001). On multivariable analysis, female sex (odds ratio [OR] 3.126, p<0.001), tumor size ≤2 cm (OR 2.335, p<0.001), lower BMI (OR 0.910 per kg/m², p<0.001), and higher eGFR (OR 1.023 per mL/min/1.73 m², p<0.001) were independently associated with benign histology.
conclusionsFemale sex, lower BMI, and smaller tumor size are significant preoperative predictors of benign histology in SRMs. These findings support consideration of active surveillance or percutaneous biopsy in patients with multiple favorable predictors to minimize overtreatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.